Digital Look

Welcome to Digital Look++,
you are not logged in

Synairgen (SNG)

Pharma and Biotech

4.63p

By Iain Gilbert

Date: Wednesday 11 Oct 2023

(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.

Synairgen posts positive results for phase 2 tri...	04-Oct-2022	ShareCast
Synairgen unveils positive clinical trial data	07-Sep-2022	ShareCast
Synairgen to collaborate with University of Sout...	05-Sep-2022	ShareCast
Synairgen posts positive clinical trial data for...	16-May-2022	ShareCast
Synairgen falls as patient recruitment halted on...	17-Mar-2022	ShareCast

Exercise of Share Options and Total Voting Rights	30-Oct-2024	18:09	RNS
Results of AGM and Appointment of New Chairman	10-Oct-2024	17:05	RNS
Interim Results	26-Sep-2024	07:00	RNS
Appointment of New Chairman and Notice of AGM	18-Sep-2024	07:00	RNS
Board Change	05-Sep-2024	07:00	RNS

AstraZeneca buys the rights to an asthma treatme...	13-Jun-2014	Daily Mail
AstraZeneca in new £138million asthma drug deal	13-Jun-2014	Express & Star

Market report: Monday latest	24-Sep-2007	Daily Mail
The Week Ahead: Wolseley should build on its sol...	24-Sep-2007	The Independent
Questor: Synairgen	11-May-2007	Telegraph
The Week Ahead: Wolseley investors seek calm ami...	19-Mar-2007	The Independent
Retailers the focus of City attention	18-Sep-2006	The Scotsman

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.